Tag Archives: kalphylaacism

Solntrey receives a quick FDA designation for Auraza wound gel to treat kalphylaacism ulcers

Solntrey receives a quick FDA designation for Auraza wound gel to treat kalphylaacism ulcers

Solascure Ltd (Solascure), a biotechnology company, developing innovative treatment to transform chronic wound healing, today announced that the American food and medicine administration (FDA) has granted a quick designation to the tested gel auraza wound (AWG), in the treatment of patients with kalcyphylaxis ulcers. The designation recognizes the potential of AWG in the treatment of […]